Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
Johnson & Johnson has announced the appointment of John Reed, to the Company’s Executive Committee as […]
Immunyx Pharma Selected to Join BLUE KNIGHT
Immunyx Pharma, a developer of immune modulating therapies for neutrophil-based diseases, announced it has been […]
Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the appointment of Thibaut Mongon as […]
Janssen Discontinues Collaboration and License Agreements with Bavarian Nordic in Hepatitis B and Human Papillomavirus
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the termination of its collaboration […]
Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
Johnson & Johnson (NYSE: JNJ) announced today that Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, […]
Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has approved […]
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) […]
DePuy Synthes Introduces the INHANCE ™ Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System
Today, The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes, The Orthopaedics Company […]
Ethicon's Echelon Circular Powered Stapler Associated with Major Reduction in Serious Complications Following Colorectal Surgery
Ethicon, part of the Johnson & Johnson Medical Devices Companies, today announced the results of […]
MedTech Innovator Selects 20 Premier Startups for Annual Asia Pacific Accelerator
MedTech Innovator, the largest accelerator of medical device companies in the world, in partnership with Asia […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more